Evidence map›Paper›PMID 36950385›Full record

ArticleCell genomics2023

Single nucleus multiomics identifies ZEB1 and MAFB as candidate regulators of Alzheimer's disease-specific

Ashlyn G Anderson, Brianne B Rogers, Jacob M Loupe, Ivan Rodriguez-Nunez, Sydney C Roberts, Lauren M White, J Nicholas Brazell, William E Bunney, Blynn G Bunney, Stanley J Watson and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Epigenomic priming of microglia bridges psychopathology and late-life cognitive decline.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  5. Distinct cell type-specific mechanisms underlie cognitive dysfunction during persistent integrated stress response activation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Decoding neurodegeneration one cell at a time.The Journal of clinical investigation · 2026
    Review
  12. Promoter mutagenesis and a massively parallel reporter screen of thebioRxiv : the preprint server for biology · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Ashlyn G AndersonHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
Brianne B RogersHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
Jacob M LoupeHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
Ivan Rodriguez-NunezHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
Sydney C RobertsHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
Lauren M WhiteHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
J Nicholas BrazellHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
William E BunneyDepartment of Psychiatry and Human Behavior, College of Medicine, University of California, Irvine, Irvine, CA, USA.
Blynn G BunneyDepartment of Psychiatry and Human Behavior, College of Medicine, University of California, Irvine, Irvine, CA, USA.
Stanley J WatsonMental Health Research Institute, University of Michigan, Ann Arbor, MI, USA.
J Nicholas CochranHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
Richard M MyersHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
Lindsay F RizzardiHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
HudsonAlpha Institute for Biotechnology · USUniversity of California, Irvine · USUniversity of Alabama at Birmingham · USUniversity of Michigan · US

Funding

Transcription factor function in healthy and psychiatric disorder-affected brainsR01MH110472 · NIMH · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI COOPER, GREGORY MICHAEL, MYERS, RICHARD M · 2017 to 2021
$6.0M
Regulatory mechanisms of rare non-coding variation in neurodegeneration-associated lociR00AG068271 · NIA · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI COCHRAN, JESSE N · 2021 to 2023
$725k
NIA NIH HHS R00 AG068271NIMH NIH HHS R01 MH110472
6 · The paper itself

Abstract

Cell type-specific transcriptional differences between brain tissues from donors with Alzheimer's disease (AD) and unaffected controls have been well documented, but few studies have rigorously interrogated the regulatory mechanisms responsible for these alterations. We performed single nucleus multiomics (snRNA-seq plus snATAC-seq) on 105,332 nuclei isolated from cortical tissues from 7 AD and 8 unaffected donors to identify candidate

Indexed as

Alzheimer’sAPPcis-regulatory elementMAFBmicrogliamultiomicsneuronsingle celltranscription factorZEB1

Identifiers

PMID36950385
PMCPMC10025452
OpenAlexW4318984787

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.